Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition

Journal of Vascular Surgery

Volumn 42, Issue 4, 2005, Pages 757-764

  Yamanouchi, Dai ^a,b   Banno, Hiroshi ^a   Nakayama, Masanori ^a   Sugimoto, Masayuki ^a   Fujita, Hiromine ^a   Kobayashi, Masayoshi ^a   Kuwano, Hiroyuki ^b   Komori, Kimihiro ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYOSIN; PRAVASTATIN; RHO KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CAROTID ARTERY; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DENSITOMETRY; DIET SUPPLEMENTATION; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; EVALUATION; HYDROPHILICITY; HYPERPLASIA; IMMUNOBLOTTING; IN VITRO STUDY; INTIMA; JUGULAR VEIN; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; RABBIT; SMOOTH MUSCLE FIBER; UMBILICAL VEIN; VASCULAR SMOOTH MUSCLE; VEIN GRAFT; VEIN LIGATION;

ANIMALS; BIOPSY, NEEDLE; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; GRAFT REJECTION; GRAFT SURVIVAL; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JUGULAR VEINS; MALE; PRAVASTATIN; PREOPERATIVE CARE; PROBABILITY; PROTEIN-SERINE-THREONINE KINASES; RABBITS; RANDOM ALLOCATION; REFERENCE VALUES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUNICA INTIMA; VASCULAR SURGICAL PROCEDURES;

EID: 26944494575     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2005.05.041     Document Type: Article

References (40)

1. M. Belkin, J. Knox, M.C. Donaldson, J.A. Mannick, A.D. Whittemore Infrainguinal arterial reconstruction with nonreversed greater saphenous vein J Vasc Surg 24 1996 957 962
2. M.G. Davies, P.O. Hagen Pathophysiology of vein graft failure a review Eur J Vasc Endovasc Surg 9 1995 7 18
3. J.G. Motwani, E.J. Topol Aortocoronary saphenous vein graft disease pathogenesis, predisposition, and prevention Circulation 97 1998 916 931
4. J.L. Goldstein, M.S. Brown Regulation of the mevalonate pathway Nature 343 1990 425 430
5. B. Pitt, G.B. Mancini, S.G. Ellis, H.S. Rosman, J.S. Park, M.E. McGovern Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I) reduction in atherosclerosis progression and clinical events. PLAC I investigation J Am Coll Cardiol 26 1995 1133 1139
6. F.M. Sacks, M.A. Pfeffer, L.A. Moye, J.L. Rouleau, J.D. Rutherford, T.G. Cole The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels Cholesterol and Recurrent Events Trial investigators N Engl J Med 335 1996 1001 1009
7. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease the Scandinavian Simvastatin Survival Study (4S) Lancet 1994 383 389
8. P. Negre-Aminou, A.K. van Vliet, M. van Erck, G.C. van Thiel, R.E. van Leeuwen, L.H. Cohen Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types Biochim Biophys Acta 1345 1997 259 268
9. M.B. Harris, M.A. Blackstone, S.G. Sood, C. Li, J.M. Goolsby, V.J. Venema Acute activation and phosphorylation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors Am J Physiol Heart Circ Physiol 287 2004 H560 H566
10. L. VanAelst, C. D'Souza-Schorey Rho GTPases and signaling networks Genes Dev 11 1997 2295 2322
11. K. Komori, P. Gloviczki, R.G. Bourchier, V.M. Miller, P.M. Vanhoutte Endothelium-dependent vasorelaxations in response to aggregating platelets are impaired in reversed vein grafts J Vasc Surg 12 1990 139 147
12. S. Ohta, K. Komori, Y. Yonemitsu, T. Onohara, T. Matsumoto, K. Sugimachi Intraluminal gene transfer of endothelial cell-nitric oxide synthase suppresses intimal hyperplasia of vein grafts in cholesterol-fed rabbit a limited biological effect as a result of the loss of medial smooth muscle cells Surgery 131 2002 644 653
13. J. Okazaki, K. Komori, K. Kawasaki, D. Eguchi, M. Ishida, K. Sugimachi L-arginine inhibits smooth muscle cell proliferation of vein graft intimal thickness in hypercholesterolemic rabbits Cardiovasc Res 36 1997 429 436
14. H. Shimokawa, K. Morishige, K. Miyata, T. Kandabashi, Y. Eto, I. Ikegaki Long-term inhibition of Rho-kinase induces a regression of arteriosclerotic coronary lesions in a porcine model in vivo Cardiovasc Res 51 2001 169 177
15. M.R. Soma, E. Donetti, C. Parolini, G. Mazzini, C. Ferrari, R. Fumagalli HMG CoA reductase inhibitors In vivo effects on carotid intimal thickening in normocholesterolemic rabbits Arterioscler Thromb 13 1993 571 578
16. T. Bandoh, H. Mitani, M. Niihashi, Y. Kusumi, J. Ishikawa, M. Kimura Inhibitory effect of fluvastatin at doses insufficient to lower serum lipids on the catheter-induced thickening of intima in rabbit femoral artery Eur J Pharmacol 315 1996 37 42
17. P.J. Neuvonen, T. Kantola, K.T. Kivisto Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole Clin Pharmacol Ther 63 1998 332 341
18. D. Williams, J. Feely Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors Clin Pharmacokinet 41 2002 343 370
19. S. Kwei, G. Stavrakis, M. Takahas, G. Taylor, M.J. Folkman, M.A. Gimbrone Jr Early adaptive responses of the vascular wall during venous arterialization in mice Am J Pathol 164 2004 81 89
20. M. Amano, M. Ito, K. Kimura, Y. Fukata, K. Chihara, T. Nakano Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase) J Biol Chem 271 1996 20246 20249
21. M. Ishida, K. Komori, Y. Yonemitsu, K. Taguchi, T. Onohara, K. Sugimachi Immunohistochemical phenotypic alterations of rabbit autologous vein grafts implanted under arterial circulation with or without poor distal runoff-implications of vein graft remodeling Atherosclerosis 154 2001 345 354
22. H. Itoh, K. Komori, S. Funahashi, K. Okadome, K. Sugimachi Intimal hyperplasia of experimental autologous vein graft in hyperlipidemic rabbits with poor distal runoff Atherosclerosis 110 1994 259 270
23. K. Komori, H. Inoguchi, M. Kume, T. Shoji, T. Furuyama Differences in endothelial function and morphologic modulation between canine autogenous venous and arterial grafts endothelium and intimal thickening Surgery 131 2002 S249 S255
24. H. Itoh, K. Komori, J. Okazaki, K. Mawatari, K. Kawasaki, S. Kuma The effect of probucol on intimal thickening of autologous vein grafts in hyperlipidemic rabbit Cardiovasc Surg 5 1997 497 503
25. M. Takemoto, J.K. Liao Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors Arterioscler Thromb Vasc Biol 21 2001 1712 1719
26. K. Hirata, A. Kikuchi, T. Sasaki, S. Kuroda, K. Kaibuchi, Y. Matsuura Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction J Biol Chem 267 1992 8719 8722
27. K. Kimura, M. Ito, M. Amano, K. Chihara, Y. Fukata, M. Nakafuku Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase) Science 273 1996 245 248
28. Y. Kawano, Y. Fukata, N. Oshiro, M. Amano, T. Nakamura, M. Ito Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo J Cell Biol 147 1999 1023 1038
29. U. Laufs, V.L. Fata, J.K. Liao Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase J Biol Chem 272 1997 31725 31729
30. X.F. Ming, H. Viswambharan, C. Barandier, J. Ruffieux, K. Kaibuchi, S. Rusconi Rho GTPase/Rho kinase negatively regulates endothelial nitric oxidase synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells Mol Cell Biol 22 2002 8467 8477
31. D. Williams, J. Feely Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors Clin Pharmacokinet 41 2002 343 370
32. R.M. Palmer, A.G. Ferrige, S. Moncada Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327 1987 524 526
33. U.C. Garg, A. Hassid Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells J Clin Invest 83 1989 1774 1777
34. Y. Kureishi, Z. Luo, I. Shiojima, A. Bialik, D. Fulton, D.J. Lefer The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals Nat Med 6 2000 1004 1010
35. M. Shiomi, T. Ito, Y. Hirouchi, M. Enomoto Fibromuscular cap composition is important for the stability of established atherosclerotic plaques in mature WHHL rabbits treated with statins Atherosclerosis 157 2001 75 84
36. M. Crisby, G. Nordin-Fredriksson, P.K. Shah, J. Yano, J. Zhu, J. Nilsson Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques implications for plaque stabilization Circulation 103 2001 926 933
37. W.H. Kaesemeyer, R.B. Caldwell, J. Huang, R.W. Caldwell Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions J Am Coll Cardiol 33 1999 234 241
38. A. Corsini, S. Bellosta, R. Baetta, R. Fumagalli, R. Paoletti, F. Bernini New insights into the pharmacodynamic and pharmacokinetic properties of statins Pharmacol Ther 84 1999 413 414
39. P.H. Jones, J.A. Farmer, M.D. Cressman, J.M. McKenney, J.T. Wright, J.D. Proctor Once-daily pravastatin in patients with primary hypercholesterolemia A dose response study Clin Cardiaol 14 1994 146 151
40. A. Miyazaki, T. Koga Pravastatin sodium, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, decreases serum total cholesterol in Japanese white rabbits by two different mechanisms Atherosclerosis 162 2002 299 306